FDA Approved: TIMOPTIC — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved a supplemental application for Timoptic (timolol maleate) from Bausch & Lomb, authorizing updates to the product via an NDA supplemental filing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• TIMOPTIC (timolol maleate)

Snippet

SUPPL AP for TIMOPTIC (TIMOLOL MALEATE)